376608-65-0

• 常用中文名：2-[[(3AR,4S,6R,6AS)-6-氨基四氢-2,2-二甲基-4H-环戊并-1,3-二恶茂-4-基]氧基]-乙醇 (2R,3R)-2,3-二羟基丁二酸盐
• 常用英文名：2-[[(3aR,4S,6R,6aS)-6-Aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-ethanol (2R,3R)-2,3-dihydroxybutanedioate
• CAS号：376608-65-0
• 分子式：C₁₄H₂₅NO₁₀
• 分子量：367.35
• 相关类别： 医药中间体 原料药中间体
• 发布时间：2018-12-24 18:48:05
• 更新时间：2026-07-11 10:37:39
• 替卡格雷中间体；医药中间体

名称

• 中文名: 2-[[(3aR,4S,6R,6aS)-6-氨基四氢-2,2-二甲基-4H-环戊并-1,3-二恶茂-4-基]氧基]-乙醇 (2R,3R)-2,3-二羟基丁二酸盐
• 英文名: 2-(((3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol (2R,3R)-2,3-dihydroxysuccinate
• 中文别名: 2-[[(3,4S,6R,6AS)-6-氨基四氢-2,2-二甲基-4H-环戊烯并-1,3-二氧杂环戊烷-4-基]氧基]乙醇L-酒石酸; 2-[[(3,4S,6R,6AS)-6-氨基四氢-2,2-二甲基-4H-环戊烯并-1,…; 2-{[((3,4S,6R,6AS)-6-氨基-2,2-二甲基-六氢环戊[D] [1,3]二氧四环-4-基]氧基}乙烷-1-醇; (3,4S,6R,6AS)-6-氨基四氢-2,2-二甲基-4H-环戊-1,3-二恶醇-4-基]氧]-乙醇(2R,3R)-2,3-二羟基丁二酸酯; 2-((3,4S,6R,6AS)-6-氨基-2,2-甲基四氢-3AH-环戊基[D][1,3]并二; 2-[[(3,4S,6R,6AS)-6-氨基四氢-2,2-二甲基-4H-环戊并-1,3-二恶茂; 2-(((3,4S,6R,6AS)-6-氨基-2,2-二甲基四氢-3AH-环戊烷并[D][1,3]1,3-二氧杂环戊烯-4-基)氧基)乙醇(2R,3R)-2,3-二羟基琥珀酸盐; 2-[[(3,4S,6R,6AS)-6-氨基四氢-2,2-二甲基-4H-环戊并-1,3-二恶茂-4-基]氧基]-乙醇 L-酒石酸盐; 替格瑞洛 TG-1,2-[[(3,4S,6R,6AS)-6-氨基四氢-2,2-二甲基-4H-环戊并-1,3-二恶茂-4-基]氧基]-乙醇 (2R,3R)-2,3-二羟基丁二酸盐7; 2-[[(3,4S,6R,6AS)-6-氨基; 替格瑞洛五元环中间体; 替格瑞洛(替卡格雷)中间体-二羟基丁二酸盐; TRICAELOR杂质4; 替格瑞洛杂质87 酒石酸盐; 2-[[(3,4S,6R,6AS)-6-氨基四氢-2,2-二甲基-4H-环戊并-1,3-二恶茂-4-基]氧基]-乙醇 (2R,3R)-2,3-二羟基丁二酸盐 或者 2-[[(3,4S,6R,6AS)-6-氨基四氢-2,2-二; 替卡格雷中间体2:2-[[(3,4S,6R,6AS)-6-氨基四氢-2,2-二甲基-4H-环戊并-1,3-二恶茂-4-基]氧基]-乙醇 (2R,3R)-2,3-二羟基丁二酸盐; 1,3-二氧杂环戊烷-4-基]氧基]乙醇L-酒石酸盐; 替卡格雷侧链酒石酸盐; 2-[[(3,4S,6R,6AS)-6-氨基-2,2-二甲基四氢-3AH-环戊二烯并[D][1,3]-二氧杂环戊-4-基]氧基]-1-乙醇 L-酒石酸盐; 2-((3,4S,6R,6AS)-6-氨基-2,2-甲基四氢-3AH-环戊基[D] [1,3]并二氧-4-氧)乙醇 L-酒石酸盐; 替卡格雷中间体五元环酒石酸盐; (2R,3R)-2,3-二羟基丁二酸盐; 2-[[(3,4S,6R,6AS)-6-氨基四氢-2,2-二甲基-4H-环戊并-1,3-二恶茂-4-基]氧基]-乙醇 (2R,3R)-2,3-二羟基丁二酸盐 或者 2-[[(3,4S,6R,6AS)-6-氨基四氢-2,2-二甲基-4H-环戊烯并-1,3-二氧杂环戊烷-4-基]氧基]乙醇L-酒石酸盐; 替格瑞洛相关化合物38 L-酒石酸盐; 替格瑞洛五元环; 替格瑞洛SM1; 替格瑞洛侧链1; 2-((3,4S,6R,6AS)-6-氨基-2,2-二甲基-四氢-3AH-环戊基[D] [1,3]并二氧-4-氧)乙醇 L-酒石酸盐; 替卡格雷中间体2; 2-[[(3,4S,6R,6AS)-6-氨基四氢-2,2-二甲基-4H-环戊并-1,3-二恶茂-4-基]氧基]-乙醇(2R,3R)-2,3-二羟基丁; 2-[[(3,4S,6R,6AS)-6-氨基四氢-2; 替格瑞洛中间体3; 2-{[(3,4S,6R,6AS)-6-氨基-2,2-二甲基-六氢环戊二烯并[D][1,3]二噁戊环-4-基]氧代}乙烷-1-醇; 替卡格雷中间体; 2-[[(3,4S,6R,6AS)-6-氨基四氢-2,2-二甲基-4H-环戊并-1,3-二恶茂-4-基]氧基]-乙醇 (2R,3R)-2,3-二羟基丁二酸盐; 2-{[(3,4S,6R,6AS)-6-氨基四氢-2,2-二甲基-4H-环戊并-1,3-二噁茂-4-基]氧基}-乙醇 (2R,3R)-2,3-二羟基丁二酸盐; 2-[[(3,4S,6R,6AS)-6-氨基四氢-2,2-二甲基-4H-环戊并-1,3-二恶茂-4-基]氧基]-乙醇 (2R,3R)-2,3-二羟基丁二酸盐(替格瑞洛中间体); 2-[[(3,4S,6R,6AS)-6-氨基四氢-2,2-二甲基-4H-环戊并-1,3-二恶茂-4-基]氧基]-乙醇 (2R,3R)-2,3-二羟基丁二酸盐(替卡格雷中间体); 替卡格雷中间体A1; 替卡格雷五元环中间体; 2-[[(3,4S,6R,6AS)-6-氨基四氢-2,2-二甲基-4H-环戊并-1,3-二恶茂-4-基]氧基]-乙醇 (2R,3R)-2,3-二羟基丁二酸盐(1:1); 2-[[(3,4S,6R,6AS)-6-氨基四氢-2,2-二甲基-4H-环戊烯-1,3-二氧杂环戊烯-4-基]氧基]-乙醇 (2R,3R)-2,3-二羟基丁二酸酯; 2-[[(3,4S,6R,6AS)-6-氨基四氢-2,2-二甲基-4H-环戊烯并-1,3-二氧杂环戊烷-4-基]氧基]乙醇L-酒石酸盐; 2-[(3,4S,6R,6AS)-6-氨基四氢-2,2-二甲基-4H-环戊并-1,3-二恶茂-4-基]氧基]-乙醇(2R,3R)- 2,3-二羟基丁二酸盐(APS); 2-[[(3,4S,6R,6AS)-6-氨基四氢-2,2-二甲基-4H-环戊烯并-1,3-二氧杂环戊烷-4-基]氧基]乙醇L-酒石酸盐TGM-1; 替格瑞洛TG-1; 替卡格雷杂质74; 替格瑞洛中间体TG-1; 替卡格雷中间体TGA; 2-((3,4S,6R,6AS)-6-氨基-2,2-甲基四氢-3AH-环戊基[D][1,3]并二氧-4-氧)乙醇L; 2-[[(3,4S,6R,6AS)-6-氨基四氢-2,2-二甲基-4H-环戊; 2-((3,4S,6R,6AS)-6-氨基-2,2-二甲基四氢-3AH-环戊[D]并[1,3]二氧戊环-4-基氧基)乙醇 L-酒石酸盐; 2-[[(3,4S,6R,6AS)-2,2-二甲基-6-氨基四氢-3AH-环戊并[D][1,3]二噁茂-4-基]氧基]乙醇-L-酒石酸盐; 酒石酸五元环; [[(3,4S,6R,6AS)-6-氨基四氢-2,2-二甲基-4H-环戊并-1,3-二恶茂-4-基]氧基]-乙醇 (2R,3R)-2,3-二羟基丁二酸盐; 2-[[(3,4S,6R,6AS)-6-氨基四氢-2,2-二甲基-4H-环戊并-1,3-二恶茂-4-基]氧基]-乙醇(2R,3R)-2,3-二羟基丁二酸盐,替卡格雷中间体3; (3R)-3-哌啶羧酸乙酯  替格瑞洛中间体SM3
• 英文别名: 2-((3,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yloxy)ethanol L-tat; 2-((3,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yloxy)ethanolL-taticacid; L-Valine, 3-methyl-N-(trifluoroacetyl)- (9CI) in stock; 2-(((3aR,4S,6R,6aS)-6-Amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol (2R,3R,4S,5R)-2,3,4,5-tetrahydroxyhexanedioate; 2-((3,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclop; 2-[[,4S,6R,6aS)-6-Aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-ethanol (2R,3R)-2,3-dihydroxybutanedioate; Purity Chemical Ticaelor Intermediates; 2-{[(3,4S,6R,6aS)-6-amino- 2,2-dimethyltetrahydro-3aH- cyclopenta[d][1,3]-dioxol-4-yl] oxy}-1-ethol L-ttic acid; Ticaelor side chain 1; 2-{[(3,4S,6R,6aS)-6-Amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl]oxy}ethanol Ttate; 2-[[(3,4S,6R,6aS)-6-AMinotetrahydro-2,2-diMethyl-4H-cyclopenta-1,3; 2-[[(3, 4S, 6R, 6aS)6-aMinotetrahydro-2,2-diMethyl-4-H-cyclopenta-1,3-dioxol-4-yl]oxy]-(2R,3R)-2,3-dihydroxybutanedioate ethanol; 2-(((3,4S,6R,6aS)-6-Amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol (2R,3R,4S,5R)-2,3,4,5-tetrahydroxyhexanedioate; 2-((3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yloxy)ethanol L-tataric acid; tetrahydro-3aH-cycL; 2-[[(3,4S,6R,6As)-6-Aminotetrahydro-2,2-Dimethyl-4H-Cy; 2-((3,4S,6R,6aS)-6-amino-2,2-diMethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yloxy)ethanol L-ttrate; 2-[[(3,4S,6R,6aS)-6-aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-Ethanol (2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt); 2-(((3aS,4R,6S,6-6-amino-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol (2R,3R)-2,3-dihydroxysuccinate; Ticaelor Impurity 87 Ttrate; 2-(((3aS,4R,6S,6); (3,4S,6R,6aS)-6-Aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-ethanol(2R,3R)-2,3-dihydroxybutanedioate; 2-((3,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yloxy)ethanol L-tatic acid22; Tricaelor Impurity 4; 2-(((3,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol (2R,3R)-2,3-dihydroxysuccinate; Ticaelor Related Compound 38（L-Ttic acid）; 1.2-[[(3,4S,6R,6aS)-6-Aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-ethanol (2R,3R)-2,3-dihydroxybutanedioate; 2-[[(3,4S,6R,6aS)-6-amino-2,2-dimethyl-tetrahydro-3aH-cyclopenta[d][1,3]-dioxol-4-yl]oxy]-1-ethanol L-ttrate; Ticaelor InterMediate 2; 2-((3,4S,6R,6aS)-6-amino-2,2-diMethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yloxy)ethanol L-ttic acid; Ethanol, 2-[[(3aR,4S,6R,6aS)-6-aminotetrahydro-2,2-dimethyl-4H-cyclopenta[d]-1,3-dioxol-4-yl]oxy]-, compd. with L-altraric acid (1:1); 2-((3,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yloxy)ethanol L-tatic acid ISO 9001：2015 REACH; 2-((3,4S,6R,6aS)-6-amino-2,2-diMethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yloxy)ethanol L-tatic aci; 2-{[(3aR,4S,6R,6aS)-6-Amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl]oxy}ethanol - L-altraric acid (1:1); 2-[[(3,4S,6R,6aS)-6-Aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-ethanol(2R,3R); Ethanol, 2-[[(3,4S,6R,6aS)-6-aMinotetrahydro-2,2-diMethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-, (2R,3R)-2,3-dihydroxybutanedioate (1:1); 2-[[(3,4S,6R,6aS)-6-Aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-ethanol (2R,3R)-2,3-dihydroxybutanedioate; 2 - [[(3 , 4 s, 6 r, as) - 6 - hydrogen amino , 2 - dimethyl - 4 h - ring e shigeru and evil - 1, -4 - base] oxygen radicals] ethanol (2 r, 3 r) - 2, 3 - dihydroxy succinic acid salt; openta[d][1,3]dioxoL; 2-[((3,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy]-1-ethanol; 2-[[(3,4S,6R,6AS)-6-AMINOTETRAHYDRO-2,2-DIMET; 2-[[(3,4S,6R,6aS)-6-Aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl; Ticaelor Intermediates 3-Cboxy-2,3-dihydroxy-propionate6-(2-hydroxy-ethoxy)-2,2-dimethyl-tetrahydro-cyclopenta[1,3]dioxol-4; (2R,3R)-2,3-dihydroxybutanedioic acid 2-{[(3,4S,6R,6aS)-6-amino-2,2-dimethyl-hexahydrocyclopenta[d][1,3]dioxol-4-yl]oxy}ethan-1-ol; 2-((3,4s,6r,6as)-6-amino-2,2-dimethyltetrahydro-3ah-cyclopenta[d][1,3]dioxol-4-yloxy)ethanol l-talic acid; 2-(((3,4S,6R,6aS)-6-Amino-2,2-dimethyL; 2-((3,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yloxy)ethanol L-tatic acid(1:1); Ethanol, 2-[[(3,4S,6R,6aS)-6-aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt); 2-((3,4R,6R,6-6-Amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yloxy)ethanol L-tatic acid; 2-(((3,4S,6R,6aS)-6-Amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d]-[1,3]dioxol-4-yl)oxy)etha; ((3,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yloxy)ethanol L-tatic acid; 2-((3,4S,6R,6aS)-6-amino-2,2-diMethyltetrahydro-3aH-cyclopenta[d] [1,3]dioxol-4-yloxy)ethanol L-Ttic Acid(1:1); 2-[((3,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy]-1-ethanol L-ttic acid salt; 2-(((3,4S,6R,6aS)-6-Amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d]-[1,3]dioxol-4-yl)oxy)ethanol (2R,3R,4S,5R)-2,3,4,5-tetrahyd; Ticaelor intermediate; Ethanol, 2-[[(3,4S,6R,6aS)-6-aMinotetrahydro-2,2-diMethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt) (9CI); 2-[{(3αR,4S,6R,6αS)-6-amino-2,2-dimethyltetrahydro-3αH-cyclopenta[d][1,3]dioxol-4-yl]-oxy}-ethanol L-tatic acid; 2-[[3,4s,6R,6aS)-6-Aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]ethanol-L-ttrate; 2-(((3,4S,6R,6AS)-6-AMINO-2,2-DIMETHYLTETRAHYDRO-3AH-CYCLOPENTA[D][1,3]DIOXOL-4-YL)OXY)ETHANOL (2R,3R)-2,3-DIHYDROXYSUCCINATE; 2-((3,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yloxy)ethanol L; 2-(((3,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol (2R,3R)-2,3-dihydroxysuccinate or 2-((3,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yloxy)ethanol L-tatic acid; 2-((3,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yloxy)ethanol L-tatic acid

物化性质

• 分子式: C₁₄H₂₅NO₁₀
• 分子量: 367.35
• 精确质量: 367.14784599
• PSA: 229.46000
• 储存条件: 室温

安全

• 安全声明 (欧洲): 24/25
• 海关编码: 2932999099

海关

海关编码	2932999099
中文概述	2932999099. 其他仅含氧杂原子的杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%
申报要素	品名, 成分含量, 用途
Summary	2932999099. other heterocyclic compounds with oxygen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%